Masimo | MASI - Betriebsaufwand

Aktienkurs
178.63
Täglich Wechseln
-0.08 -0.04%
Monatlich
0.30%
Jährlich
9.09%
Q2 Prognose
174.81




Betriebsaufwand Veränderung Datum
Abbott USD 9.31B 104M 2026-03
Accuray USD 37.18M 567K 2024-12
Align Technology USD 822.85M 11.8M 2025-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
General Electric Aerospace USD 18.06B 7.11B 2026-03
Globus Medical USD 645.11M 241.46M 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Orthofix International USD 213.79M 12.36M 2025-12
Owens Minor USD 708.15M 1.14B 2025-12
ResMed USD 925.21M 51.98M 2025-12
Steris USD 1.22B 28.8M 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12